Nov. 3, 2021

"compound 24"

50x family-selective HPK1 kinase inhibitor tumor clearance w/ PD-1i (oral 100 mpk BID) from IRAK4 inhibitor and homology modeling ACS. Med. Chem. Lett., Feb. 19, 2021 Bristol Myers Squibb, Cambridge, MA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in